Evaluation of luteolin in the chemoprventive effects of

azoxymethane-induced aberrant crypt foci in rat by Mahmood, A.A. & Hapipah, M.A.
Intemational Conference on Innovative Trends in Multidisciplinary Academic
Research, October 20-21, 2014. ITMAR © 2014 Istanbul, Turkey.
Global Illuminators, Kuala Lumpur, Malaysia.
EVALUATION OF LUTEOLIN IN THE
CHEMOPRVENTIVE EFFECTS OF
AZOXYMETHANE-INDVCED ABERRANT CRYPT
FOCI IN RAT
Mahmood Ameen Abdulla! and Hapipah Mohd AliI
'Department of Molecular Medicine, Faculty of Medicine, University of
Malaya, Malaysia-Department of Chemistry, Faculty of Science,
University of Malaya, Malaysia.
Correspondence: lammeen@um.edu.my
ABSTRACT
Colorectal cancer is a common. malignancy and a leading cause of cancer
death worldwide. Luteolin is an important flavonoid with a potential
anticancer effect. The aim of the present study is to evaluate the
chemoprotective effects of luteolin against azoxymethane-induced (AOM)
aberrant crypt foci (ACF) in rat's colon. Five groups of rats, Group I (normal
control) was received subcutaneous injection sterile distilled water, once
weekly for 2 weeks. Normal control rats were continued on Tween 20 feeding
for 8 weeks. Group 2 -5 were received subcutaneous injection of AOM, 15
mg/kg body weight, once weekly for 2 weeks. Group2, cancer group were
continued on 6 mg/kg cisplatin drug feeding, and experimental groups
continued on 5 and 20 mg/kg Luteolin feeding, respectively. All rats were
sacrificed after 8 weeks. Colons were evaluated grossly and histopathology
for ACF. Rats fed with Luteolin.showed significantly decreased total colonic
ACF formation, and also inhibition of foci containing four or more aberrant
crypts when compared with cancer group. Biochemistry, experimental groups
showed significant increase in Total protein, Albumin, Hb, WBC levels,
when compared with cancer group. However, Luteolin showed significant
decreased in LDH and urea when compared with Cancer group. Acute
toxicity test, Luteolin did not show any signs of toxicity and mortality up to
200 mg/kg. Histopathology confirmed the result. AOM-treated group, ACF
showed elongated crypts with loss of mucin and marked nuclear atypia. The
proliferating nuclear cell antigens (PCNA) staining was much stronger in
AOM-treated rats than in Luteolin-fed group. The colon sections from AOM-
treated group showed high number of positive cells than those from Luteolin-
fed group. Luteolin treated rats exhibited' .significant decreased
Malondialdehyde (MDA) and increased superoxide dismutase (SOD) and
catalase (CAT) in the colon tissue homogenate. In conclusion, the current
study demonstrated that 5 or 20 mg/kg Luteolin showed significant reduction
of ACF and this may be attributed to antioxidant effect and anti-proliferative
effects of Luteolin.
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